(SP5C) Lyxor SP500 - C-EUR - Ratings and Ratios
Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: LU1135865084 • US Large-Cap Blend Equity
SP5C: Stocks, Bonds, American, Equities, Investments
The Lyxor S&P 500 UCITS ETF - C-EUR (PA:SP5C) is a Luxembourg-domiciled exchange-traded fund designed to track the performance of the Morningstar US Large-Mid NR USD Index. This index focuses on large- and mid-cap U.S. equities, offering exposure to a broad range of sectors and companies in the American market.
With assets under management (AUM) of €13.246 billion, this ETF is one of the larger funds in its category, indicating significant investor interest and liquidity. It is listed on the Paris stock exchange (PA) under the ticker symbol SP5C and is classified as a US Large-Cap Blend Equity ETF, meaning it holds a mix of growth and value stocks across the U.S. market.
The fund employs a replication strategy to closely track its underlying index, ensuring minimal tracking error. Its total expense ratio (TER) is a key consideration for cost-conscious investors, as it directly impacts long-term returns. Additionally, the fund’s structure as a UCITS-compliant ETF makes it accessible to European investors while maintaining regulatory compliance.
Investors should note that the ETF does not currently report P/E, P/B, or P/S ratios, which may limit certain analytical approaches. However, its focus on large- and mid-cap U.S. equities makes it a staple for portfolios seeking diversified exposure to the American market. The fund’s liquidity and trading volume are also important factors for investors to evaluate, as they can impact execution costs and market impact.
For fund managers, this ETF serves as a straightforward tool for gaining exposure to the U.S. large- and mid-cap market without the need for direct stock selection. Its simplicity and transparency make it a popular choice for both individual and institutional investors seeking passive, index-based strategies.
Additional Sources for SP5C ETF
SP5C ETF Overview
Market Cap in USD | 12,222m |
Category | US Large-Cap Blend Equity |
TER | 0.05% |
IPO / Inception | 2014-12-09 |
SP5C ETF Ratings
Growth 5y | 89.9% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength | -0.17 |
Analysts | - |
Fair Price Momentum | 362.87 EUR |
Fair Price DCF | - |
SP5C Dividends
No Dividends PaidSP5C Growth Ratios
Growth Correlation 3m | -55.7% |
Growth Correlation 12m | 85.6% |
Growth Correlation 5y | 93% |
CAGR 5y | 18.22% |
CAGR/Max DD 5y | 1.07 |
Sharpe Ratio 12m | 1.28 |
Alpha | 1.30 |
Beta | 0.990 |
Volatility | 16.91% |
Current Volume | 10.8k |
Average Volume 20d | 8.1k |
As of March 30, 2025, the stock is trading at EUR 369.81 with a total of 10,782 shares traded.
Over the past week, the price has changed by -3.19%, over one month by -9.77%, over three months by -9.01% and over the past year by +8.28%.
Yes. Based on ValueRay Analyses, Lyxor SP500 - C-EUR (PA:SP5C) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 89.93 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SP5C as of March 2025 is 362.87. This means that SP5C is currently overvalued and has a potential downside of -1.88%.
Lyxor SP500 - C-EUR has no consensus analysts rating.
According to ValueRays Forecast Model, SP5C Lyxor SP500 - C-EUR will be worth about 402.1 in March 2026. The stock is currently trading at 369.81. This means that the stock has a potential upside of +8.73%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 402.1 | 8.7% |